Lack of correlation between invitro antibiosis and invivo protection against enteropathogenic bacteria by probiotic lactobacilli

Research in Microbiology

Volumn 165, Issue 1, 2014, Pages 14-20

  Bujalance, Carmen ^a   Jiménez Valera, María ^a   Moreno, Encarnación ^a   Ruiz López, María Dolores ^a   Lasserrot, Agustín ^b   Ruiz Bravo, Alfonso ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Parque tecnológico de Ciencias de la Salud   (Spain)

Author keywords

Antibiosis; Infection; Lactobacillus; Probiotics

Indexed keywords

GLUCOSE; PROBIOTIC AGENT;

ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM CULTURE; CONTROLLED STUDY; CORRELATIONAL STUDY; EXPERIMENTAL INFECTION; FERMENTATION; IN VITRO STUDY; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BREVIS; LACTOBACILLUS CASEI; LACTOBACILLUS COPROPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTECTION; SALMONELLA TYPHIMURIUM; YERSINIA ENTEROCOLITICA; ANIMAL; ENTEROBACTERIACEAE INFECTION; FECES; FEMALE; INFECTION; MICROBIOLOGY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LISTERIA MONOCYTOGENES; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; YERSINIA ENTEROCOLITICA;

ANTIBIOSIS; INFECTION; LACTOBACILLUS; PROBIOTICS;

ANIMALS; ANTIBIOSIS; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; LACTOBACILLUS; LISTERIA MONOCYTOGENES; MICE; PROBIOTICS; SALMONELLA TYPHIMURIUM; YERSINIA ENTEROCOLITICA;

EID: 84893754556     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2013.10.006     Document Type: Article

References (41)

1. Annuk H., Shchepetova J., Kullisaar T., Songisepp E., Zilmer M., Mikelsaar M. Characterization of intestinal lactobacilli as putative probiotic candidates. J. Appl. Microbiol. 2003, 94:403-412.
2. Bermúdez-Brito M., Plaza-Diaz J., Muñoz-Quezada S., Gómez-Llorente C., Gil A. Probiotic mechanisms of action. Ann. Nutr. Metab. 2012, 61:160-174.
3. Bernet-Camard M.F., Liévin V., Brassart D., Neeser J.R., Servin A.L., Hudault S. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active invitro and invivo. Appl. Environ. Microbiol. 1997, 63:2747-2753.
4. Bujalance C., Jimenez-Valera M., Moreno E., Ruiz-Bravo A. A selective differential medium for Lactobacillus plantarum. J. Microbiol. Methods 2006, 66:572-575.
5. Bujalance C., Moreno E., Jimenez-Valera M., Ruiz-Bravo A. A probiotic strain of Lactobacillus plantarum stimulates lymphocyte responses in immunologically intact and immunocompromised mice. Int. J. Food Microbiol. 2007, 113:28-34.
6. Carmody R.J., Chen Y.H. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell. Mol. Immunol. 2007, 4:31-41.
7. Coconnier M.H., Lievin V., Bernet-Camard M.F., Hudault S., Servin A.L. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob. Agents Chemother. 1997, 41:1046-1052.
8. De Vrese M., Schrezenmeir J. Probiotics, prebiotics and synbiotics. Adv. Biochem. Eng. Biotechnol. 2008, 111:1-66.
9. Dicks L.M.T., Botes M. Probiotic lactic acid bacteria in the gastro-intestinal tract: health benefits, safety and mode of action. Benef. Microbes 2010, 1:11-29.
10. Dunne C., O'Mahony L., Murphy L., Thornton G., Morrissey D., O'Halloran S., Feeney M., Flynn S., Fitzgerald G., Daly C., Kiely B., O'Sullivan G.C., Shanahan F., Collins J.K. Invitro selection criteria for probiotic bacteria of human origin: correlation with invivo findings. Am. J. Clin. Nutr. 2001, 73:386S-392S.
11. FAO/WHO Guidelines for the Evaluation of Probiotics in Food 2002, Food and Agriculture Organization of the United Nations and World Health Organization, Working Group Report. (Online).
12. Fernandez M.F., Boris S., Barbes C. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J. Appl. Microbiol. 2003, 94:449-455.
13. Fuentes S., Egert M., Jimenez-Valera M., Monteoliva-Sanchez M., Ruiz-Bravo A., Smidt H. A strain of Lactobacillus plantarum affects segmented filamentous bacteria in the intestine of immunosuppressed mice. FEMS Microbiol. Ecol. 2008, 63:65-72.
14. Fuentes S., Egert M., Jiménez-Valera M., Ramos-Cormenzana A., Ruiz-Bravo A., Smidt H., Monteoliva-Sanchez M. Administration of Lactobacillus casei and Lactobacillus plantarum affects the diversity of murine intestinal lactobacilli, but not the overall bacterial community structure. Res. Microbiol. 2008, 159:237-243.
15. Fuller R. Probiotics in man and animals. J. Appl. Bacteriol. 1989, 66:365-378.
16. Gibson G.R., McCartney A.L., Rastall R.A. Prebiotics and resistance to gastrointestinal infections. Br. J. Nutr. 2005, 93:S31-S34.
17. Gill H.S., Shu Q., Lin H., Rutherfurd K.J., Cross M.L. Protection against translocating Salmonella typhimurium infection in mice by feeding the immno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med. Microbiol. Immunol. 2001, 190:97-104.
18. Guarner F., Schaafsma G.J. Probiotics. Int. J. Food Microbiol. 1998, 39:237-238.
19. Hisbergues M., Magi M., Rigaux P., Steuve J., García L., Goudercourt D., Pot B., Peste J., Jacques A. Invivo and invitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria. Clin. Exp. Allergy 2007, 37:1286-1295.
20. Isolauri E. Modification of viral diarrhoea by probiotics. Probiotics 3, Immunomodulation by the Gut Microflora and Probiotics 2000, 139-147. Kluwer Academic Publishers, Dordrecht. R. Fuller, G. Perdigon (Eds.).
21. Jacobsen C.N., Nielsen V.R., Hayford A.E., Moller P.L., Michaelsen K.F., Paerregaard A., Sandstrom B., Tvede M., Jakobsen M. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by invitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl. Environ. Microbiol. 1999, 65:4949-4956.
22. Kanmani P., Kumar R.S., Yuvaraj N., Paari K.A., Pattukumar V., Arul V. Probiotics and its functionally valuable products. A review. Crit. Rev. Food Sci. Nutr. 2013, 53:641-658.
23. Leber S., Vanderleyden J., De Keersmaecker S.C.J. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 2008, 72:728-764.
24. Marteau P., Seksik P., Jian R. Probiotics and health: new facts and ideas. Curr. Opin. Biotech. 2002, 13:486-489.
25. Mazigh D., Alonso J.M., Mollaret H.H. Simple method for demonstration of differential colony morphology of plasmid-associated virulent clones of Yersinia enterocolitica. J. Clin. Microbiol. 1983, 17:555-557.
26. Mobley H.L., Island M.D., Hausinger R.P. Molecular biology of microbial ureases. Microbiol. Rev. 1995, 59:451-480.
27. Ouwehand A., Salminen S., Isolauri E. Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek 2002, 82:279-289.
28. Puertollano E., Puertollano M.A., Cruz-Chamorro L., Alvarez de Cienfuegos G., Ruiz-Bravo A., de Pablo M.A. Orally administered Lactobacillus plantarum reduces pro-inflammatory interleukin secretion in sera from Listeria monocytogenes infected mice. Br. J. Nutr. 2008, 99:819-825.
29. Puertollano E., Puertollano M.A., Cruz-Chamorro L., Alvarez de Cienfuegos G., Ruiz-Bravo A., de Pablo M.A. Effects of concentrated supernatants recovered from Lactobacillus plantarum on Escherichia coli growth and on the viability of a human promyelocytic cell line. J. Appl. Microbiol. 2009, 106:1194-1203.
30. Reid G., Jass J., Sebulsky M.T., McCormick J.K. Potential use of probiotics in clinical practice. Clin. Microbiol. Rev. 2003, 16:658-672.
31. Reuter G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr. Issues Intestinal Microbiol. 2001, 2:43-53.
32. Robins-Browne R.M. Yersinia enterocolitica. Food Microbiology 1997, 192-215. ASM Press, Washington. P.M. Doyle, L.R. Beuchat, T.J. Montville (Eds.).
33. Rolfe R.D. The role of probiotic cultures in the control of gastrointestinal health. J. Nutr. 2000, 130(2S):396S-402S.
34. Sanders M.E. Probiotics: consideration for human health. Nutr. Rev. 2003, 61:91-99.
35. Schillinger U., Lücke F.K. Antibacterial activity of Lactobacillus sake isolated from meat. Appl. Environ. Microbiol. 1989, 55:1901-1906.
36. Servin A.L. Antagonist activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev. 2004, 28:405-440.
37. Sullivan A., Nord C.E. The place of probiotics in human intestinal infections. Int. J. Antimicrob. Agents 2002, 20:313-319.
38. Timmerman H.M., Niers L.E.M., Ridwan B.U., Koning C.J.M., Mulder L., Akkermans L.M.A., Rombouts F.M., Rijkers G.T. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin. Nutr. 2007, 26:450-459.
39. Ventura M., Turroni F., van Sinderen D. Probiogenomics as a tool to obtain genetic insights into adaptation of probiotic bacteria to the human gut. Bioeng. Bugs 2012, 3:73-79.
40. Wagner R.D., Pierson C., Warner T., Dohnalek M., Farmer J., Roberts L., Hilty M., Balish E. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect. Immun. 1997, 65:4165-4172.
41. Zoumpopoulou G., Foligne B., Christodoulou K., Grangette C., Pot B., Tsakalidou E. Lactobacillus fermentum ACA-DC 179 displays probiotic potential invitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models. Int. J. Food Microbiol. 2008, 121:18-26.